[Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study]
- PMID: 3672070
[Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study]
Abstract
Clinical aspects of 924 unselected patients with hyperthyroidism from 17 thyroid centres of 6 European countries were investigated in a prospective study for exactly 1 year. Serum samples were centrally assayed for thyroid hormones, thyroid autoantibodies and TSH-binding inhibiting immunoglobulins (TBII), and urine samples for iodine. 26 items of information per patient were computerized and evaluated. Forming 2 groups from iodine-deficient areas (IDA) and iodine-sufficient (ISA) according to the urinary iodine, it was possible to elucidate some characteristics independently of local factors. The most important findings were: 1. Three types of hyperthyroidism were described: Graves' disease was defined as hyperthyroidism with eye symptoms and/or the presence of measurable TBII; autonomous adenomas were defined by a single hot nodule in the thyroid scan; the remainder included TBII negative hyperthyroid patients as well as non-immunogenic forms of hyperthyroidism (toxic multinodular goiter and other multifocal autonomies). These were termed "non-classifiable" patients. Graves' patients, representing an average of 60% of the patients, have an age peak between 40 and 49 years; they are 10 years younger than unclassified hyperthyroid patients and 20 years younger than patients with autonomous adenoma, who represented 9.2% of the patients. Surprisingly, there was no difference in the prevalence of Graves' disease between IDA and ISA. 2. An unexpectedly high rate of 10.5% of hyperthyroid patients (Graves' disease 8.5%, non-Graves' disease 14.2%) had no goiter, a figure increasing in the elderly to almost 17%. In IDA the thyroid was larger and the goiter more often nodular than in ISA. IDA are characterized by significantly higher rates (11.3%) of autonomous adenoma than ISA (3.2%). 3. 59.4% of 507 patients with Graves' disease had eye symptoms, 44.6% of at least grade II or higher using the Werner classification. There was no difference between patients from ISA and IDA. We found unilateral ophthalmopathy in 6.7% of Graves' patients. 4. The median iodine excretion was calculated from urinary iodine after exclusion of values over 250 micrograms iodine/g creatinine, arbitrarily defined as iodine contamination. In IDA the median iodine excretion was 63.6, and in ISA 105 micrograms/g of creatinine. 5. Surprisingly, proven iodine contamination was as frequent in IDA (14.5%) as in ISA (15.2%). In the survey protocol, however, this was noticed less often by physicians in ISA.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
The different types of hyperthyroidism in Europe. Results of a prospective survey of 924 patients.J Endocrinol Invest. 1988 Mar;11(3):193-200. doi: 10.1007/BF03350134. J Endocrinol Invest. 1988. PMID: 3372959
-
Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.Clin Endocrinol (Oxf). 2008 Aug;69(2):311-7. doi: 10.1111/j.1365-2265.2008.03192.x. Epub 2008 Jan 18. Clin Endocrinol (Oxf). 2008. PMID: 18208575
-
[Clinical aspects, diagnosis and drug therapy of hyperthyroidism].Schweiz Med Wochenschr. 1995 Aug 8;125(31-32):1489-94. Schweiz Med Wochenschr. 1995. PMID: 7545825 German.
-
TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.Exp Clin Endocrinol Diabetes. 2004 Apr;112(4):171-4. doi: 10.1055/s-2004-817930. Exp Clin Endocrinol Diabetes. 2004. PMID: 15127319 Review.
-
Epidemiology of thyroid diseases in iodine sufficiency.Thyroid. 1998 Dec;8(12):1179-83. doi: 10.1089/thy.1998.8.1179. Thyroid. 1998. PMID: 9920375 Review.
Cited by
-
Need for an individualized and aggressive management of multinodular goiters of endemic zones by specially trained surgeons: experience in western Nepal.World J Surg. 2006 Dec;30(12):2101-9; discussion 2110-1. doi: 10.1007/s00268-005-0346-9. World J Surg. 2006. PMID: 17103103
-
[Iodine therapy for iodine deficiency goiter and autoimmune thyroiditis. A prospective study].Med Klin (Munich). 1999 Nov 15;94(11):597-602. doi: 10.1007/BF03044999. Med Klin (Munich). 1999. PMID: 10603730 Clinical Trial. German.
-
Mild Thyrotoxicosis due to Seronegative Graves' Disease or Disseminated Thyroid Autonomy.AACE Clin Case Rep. 2024 Dec 5;11(2):102-106. doi: 10.1016/j.aace.2024.12.002. eCollection 2025 Mar-Apr. AACE Clin Case Rep. 2024. PMID: 40201472 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical